Featured Video


A Mark of Success?
Achim Schneeberger, MD, talks about the Phase II study that demonstrated…



An epilepsy drug treating cognitive impairment in #alzheimers is moving to Phase III http://t.co/eQwFnJAYT6 http://t.co/oKs2qXqgN7



In Wake of Actavis/Allergan Deal, CEOs Eye Growth

In the year’s largest acquisition in any industry, Dublin, Ireland based specialty and generic drugmaker Actavis announced plans to acquire Allergan for $66 billion in cash …

Nuplazid Submission For Parkinson’s Psychosis Delayed

Acadia Pharmaceuticals says it has pushed back their tar- geted release date of the New Drug Application (NDA) for Nuplazid, a Parkinson’s disease psychosis therapy. The com…

Migraine Treatment on Hold

Originally expecting an approval decision by the end of November, Avanir Pharmaceuticals’ experimental migraine drug-device has been delayed. AVP-825 is a drug-device com…

Data Show Zetia Plus Statin Reduces Risk for CVEs

A nearly decade-long study shows that the cholesterol drug Zetia (ezetimibe) lowered the risk of heart attacks and strokes in high-risk heart patients when it was used with an…

Promising Phase II Results Seen for Parkinson’s Drug

Cynapsus Therapeutics released positive top-line results from its CTH-105 Phase II clinical trial of APL-130277 for the management of “off” motor symptoms of Parkinson’s…

Featured NeuroTopic


Movement Disorders

physician counsel

Curated by Bryn Mawr Communications II and Endovascular Today

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.


Contact Info

For advertising rates and opportunities:
Steve Farrell

For further information:
Alan Guralnick
Group Publisher
(484) 581-1832

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

Website Design by Sides Media